Curcumin attenuates ischemia-like injury induced IL-1β elevation in brain microvascular endothelial cells via inhibiting MAPK pathways and nuclear factor-κB activation

Neurological Sciences

Volumn 35, Issue 9, 2014, Pages 1387-1392

  Dong, Hua Jiang ^a,b   Shang, Chong Zhi ^b   Peng, Ding Wei ^b   Xu, Jian ^b   Xu, Peng Xiao ^b   Zhan, Li ^b   Wang, Peng ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Brain microvascular endothelial cell; Curcumin; IL 1 ; MAP kinase; NF B

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIINFLAMMATORY AGENT; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRROLIDINE DITHIOCARBAMATE; STRESS ACTIVATED PROTEIN KINASE; ENZYME INHIBITOR; GLUCOSE; IMIDAZOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN; BRAIN ISCHEMIA; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANATOMY AND HISTOLOGY; ANIMAL; ANOXIA; CELL CULTURE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; MICROVASCULATURE; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANOXIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CELLS, CULTURED; CURCUMIN; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GLUCOSE; IMIDAZOLES; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; L-LACTATE DEHYDROGENASE; MALE; MICROVESSELS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84908356411     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1718-4     Document Type: Article

References (31)

1. Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127-136 (Pubitemid 36176947)
2. Li W, Li P, Hua Q et al (2009) The impact of paracrine signaling in brain microvascular endothelial cells on the survival of neurons. Brain Res 1:28-38
3. Wang J, Li PT, Du H et al (2011) Impact of paracrine signals from brain microvascular endothelial cells on microglial proliferation and migration. Brain Res Bull 86:53-59
4. Gupta SC, Patchva S, Koh W et al (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39:283-299
5. Wang Q, Sun AY, Simonyi A et al (2005) Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res 82:138-148 (Pubitemid 41604805)
6. Jiang J, Wang W, Sun YJ et al (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 561:54-62 (Pubitemid 46435844)
7. Zhao J, Yu S, Zheng W et al (2010) Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 35:374-379
8. Wu J, Li Q, Wang X et al (2013) Neuroprotection by curcumin in ischemic brain injury involves the akt/nrf2 pathway. PLoS One 8:e59843
9. Wang YF, Gu YT, Qin GH et al (2013) Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells. J Mol Neurosci 51:344-351
10. Zhang L, Zq LIANG (2008) Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in vitro. Acta Pharmacol Sin 29:800-807
11. Perriere N, Demeuse P, Garcia E et al (2005) Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 93:279-289 (Pubitemid 40547485)
12. Chen D, Nie M, Fan M-w et al (2008) Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology 82:264-269
13. Abe Y, Hashimoto S, HORIE T (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39:41-47
14. Wang S-L, Li Y, Wen Y et al (2009) Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed Environ Sci 22:32-39
15. Ranjan D, Chen C, Johnston TD et al (2004) Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J Surg Res 121:171-177 (Pubitemid 39387457)
16. Cohen AN, Veena MS, Srivatsan ES et al (2009) Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. Arch Otolaryngol Head Neck Surg 135:190-197
17. Stanimirovic D, Satoh K (2000) Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol 10:113-126 (Pubitemid 30056399)
18. Feuerstein GZ, Wang X, Barone FC (1998) The role of cytokines in the neuropathology of stroke and neurotrauma. NeuroImmunomodulation 5:143-159 (Pubitemid 28417026)
19. Maddahi A, Edvinsson L (2010) Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation 7:14
20. Irving EA, Barone FC, Reith ADet al (2000) Differential activation of MAPK/ERK and p38/SAPKin neurones and glia following focal cerebral ischaemia in the rat. Mol Brain Res 77:65-75 (Pubitemid 30256193)
21. Hayashi T, K-i Sakai, Sasaki C et al (2000) c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett 284:195-199 (Pubitemid 30204546)
22. Irving EA, Bamford M (2002) Role of mitogen-and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647 (Pubitemid 34596455)
23. Okami N, Narasimhan P, Yoshioka H et al (2012) Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase. J Cereb Blood Flow Metab 33:106-114
24. Wallace BK, Jelks KA, O'Donnell ME (2012) Ischemia-induced stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransport involves p38 and JNK MAP kinases. Am J Physiol Cell Physiol 302:C505-C517
25. Li J, Li Y, Ogle M et al (2010) dl-3-n-Butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway. Brain Res 1359:216-226
26. Benakis C, Bonny C, Hirt L (2010) JNK inhibition and inflammation after cerebral ischemia. Brain Behav Immun 24:800-811
27. Dogra C, Changotra H, Mohan S et al (2006) Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem 281:10327-10336 (Pubitemid 43864571)
28. Nonn L, Duong D, Peehl DM (2007) Chemopreventive antiinflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis 28:1188-1196 (Pubitemid 47062677)
29. Craig R, Larkin A, Mingo AM et al (2000) p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem275:23814-23824 (Pubitemid 30624667)
30. Carter AB, Knudtson KL, Monick MM et al (1999) The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression. The role of tata-binding protein (TBP). J Biol Chem 274:30858-30863
31. Berghe WV, Plaisance S, Boone E et al (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273:3285-3290 (Pubitemid 28109741)